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DOTA-Y3-Octreotate (DOTA-TATE) and other somatostatin analogs can be labeled 
with radionuclides for cancer-fighting applications. Specifically, the radiolanthanides are 
of great interest to the radiopharmaceutical industry because of their similar chemistries 
and assortment of radioactive properties. Terbium-161 (161Tb) is considered ideal for 
both radiotherapy and imaging because of its half-life (6.91 days), beta (0.59 MeV) and 
gamma (46-48 and 74 keV) emissions. In addition, carrier-free 161Tb will have a high 
specific activity, meaning less drug mass is necessary to deliver the required dose to 
the neuroendocrine tumor. Radioactive terbium was obtained at the University of 
Missouri Research Reactor (MURR) via neutron capture on gadolinium-160 (160Gd) to 
form gadolinium-161 (161Gd), which beta decays to 161Tb. To obtain carrier-free 161Tb, 
160Gd contaminant was isolated from 161Tb using ion-exchange liquid chromatography. 
Various parameters were tested to optimize conditions for labeling DOTA-TATE with 
161Tb: pH, buffer concentration, sample volume, incubation time using a water bath, and 
amount of activity. 161Tb-DOTA-TATE solution was reacted in 0.4 M, pH 7 ammonium 
acetate (NH4OAc ) under 80˚C for 1 h. However, an experiment using lutetium-177 
showed that only 5 minutes in the water bath was necessary for labeling. We 
determined the concentration of the NH4OAc buffer solution was insignificant as long as 
pH was maintained above 5. We observed a maximum labeling level of 65 μCi of 161Tb 
per microgram of DOTA-TATE. Future work will include a stability study of the labeled 
DOTA-TATE and modifications to the preparation of the terbium sample in order to 
achieve more activity per microgram of the chelate as required by animal studies. 
